KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 9 filers reported holding KAZIA THERAPEUTICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | -13.8% | 25 | 0.0% | 0.00% | – |
| Q2 2023 | $29 | +11.5% | 25 | 0.0% | 0.00% | – |
| Q1 2023 | $26 | -43.5% | 25 | -66.7% | 0.00% | – |
| Q4 2022 | $46 | – | 75 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 75 | -25.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -100.0% | 100 | -50.0% | 0.00% | – |
| Q1 2021 | $2,480,000 | +247900.0% | 200 | +100.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 100 | -69.2% | 0.00% | – |
| Q2 2020 | $1,000 | – | 325 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 325 | -43.5% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 575 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 575 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 575 | +4.5% | 0.00% | – |
| Q3 2018 | $2,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NewEdge Advisors, LLC | 500 | $515 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 200 | $206 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 199,450 | $205,453 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 68,224 | $70 | 0.00% |
| Steward Partners Investment Advisory, LLC | 25 | $26 | 0.00% |
| AdvisorNet Financial, Inc | 5 | $5 | 0.00% |
| Belpointe Asset Management LLC | 3,000 | $3,090 | 0.00% |
| Allworth Financial LP | 87 | $90 | 0.00% |